1. Home
  2. BYND vs ORGO Comparison

BYND vs ORGO Comparison

Compare BYND & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Meat Inc.

BYND

Beyond Meat Inc.

HOLD

Current Price

$10.21

Market Cap

231.6M

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$1.49

Market Cap

239.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYND
ORGO
Founded
2009
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
231.6M
239.3M
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
BYND
ORGO
Price
$10.21
$1.49
Analyst Decision
Sell
Strong Buy
Analyst Count
7
2
Target Price
$0.83
$8.50
AVG Volume (30 Days)
10.4M
638.3K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
24.69
1600.00
EPS
N/A
N/A
Revenue
$275,496,000.00
$564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.36
$26.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.04
52 Week Low
$0.40
$1.54
52 Week High
$15.47
$7.08

Technical Indicators

Market Signals
Indicator
BYND
ORGO
Relative Strength Index (RSI) 55.82 30.07
Support Level $0.65 N/A
Resistance Level $15.47 $2.58
Average True Range (ATR) 0.75 0.09
MACD -0.71 0.00
Stochastic Oscillator 2.33 0.00

Price Performance

Historical Comparison
BYND
ORGO

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: